ⓘ Duvortuxizumab

                                     

ⓘ Duvortuxizumab

Duvortuxizumab is a chimeric/humanized monoclonal antibody designed for the treatment of B-cell malignancies.

This drug was developed by Janssen global services.

                                     
  • human PD - L1 Y cancer Dusigitumab mab human ILGF2 B - cell malignancies Duvortuxizumab scFv chimeric humanized CD19, CD3E cancer Ecromeximab mab chimeric GD3